Detalhe da pesquisa
1.
MMS19 as a potential predictive marker of adjuvant chemotherapy benefit in resected non-small cell lung cancer.
Cancer Biomark
; 17(3): 323-333, 2016 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27802208